EcoDrugPlus

Cytidine Deaminase

Ensembl ID : ENSMMMG00000019713
Gene Symbol: CDA
3 Cross references
224 Possible Orthologues:

Cytochrome P450 3a9-Like

Ensembl ID : ENSMMMG00000005149
Gene Symbol: LOC107155933
2 Cross references
623 Possible Orthologues:

Cytochrome P450 3a9-Like

Ensembl ID : ENSMMMG00000006168
Gene Symbol: LOC107133689
2 Cross references
623 Possible Orthologues:

Cytochrome P450 3a9-Like

Ensembl ID : ENSMMMG00000005108
Gene Symbol: LOC107155932
2 Cross references
623 Possible Orthologues:

Cytochrome P450 3a9-Like

Ensembl ID : ENSMMMG00000005062
Gene Symbol: LOC107155930
2 Cross references
623 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSMMMG00000023378
Gene Symbol: CYP17A1
3 Cross references
210 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSMMMG00000016103
Gene Symbol: CYP19A1
3 Cross references
315 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSMMMG00000014654
Gene Symbol: CYP26A1
3 Cross references
207 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSMMMG00000002348
Gene Symbol: CYP46A1
3 Cross references
259 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSMMMG00000007924
Gene Symbol: DGAT1
3 Cross references
260 Possible Orthologues:

Dihydrofolate Reductase

Ensembl ID : ENSMMMG00000007718
Gene Symbol: DHFR
2 Cross references
353 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSMMMG00000013750
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).